FDA inspection
DeGowin Blood Center: FDA inspection ending Dec 12, 2024
FDA inspection 1259069 · No Action Indicated (NAI) · Iowa City, IA
Key facts
| Inspection ID | 1259069 |
|---|---|
| Firm | DeGowin Blood Center |
| FEI number | 1972918 |
| Address | 200 Hawkins Dr |
| City | Iowa City |
| State | IA |
| ZIP | 52242 |
| Country | United States |
| Fiscal year | 2025 |
| Inspection end date | Dec 12, 2024 |
| Classification | No Action Indicated (NAI) |
| Project area | Blood and Blood Products |
| Product type | Biologics |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data